202 related articles for article (PubMed ID: 19793999)
1. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study: response to Kramer et al.
Oda E; Kawai R
Diabetes Care; 2009 Oct; 32(10):e125; author reply e126. PubMed ID: 19793999
[No Abstract] [Full Text] [Related]
2. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.
Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
J Intern Med; 2010 Jun; 267(6):561-6. PubMed ID: 20337857
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study.
Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
Diabetes Care; 2009 Jul; 32(7):1272-3. PubMed ID: 19366963
[TBL] [Abstract][Full Text] [Related]
4. Elevated fasting glucose levels predicts IGT and diabetes also in middle-age subjects.
Schwarz PE; Bornstein SR; Hanefeld M
Diabetes Res Clin Pract; 2007 Jul; 77(1):148-50. PubMed ID: 17092598
[TBL] [Abstract][Full Text] [Related]
5. [Uric acid predicts type 2 diabetes mellitus in the general population].
Cardona F; Rojo-Martínez G; de la Cruz Almaraz M; Soriguer F; García-Fuentes E; Tinahones FJ
Endocrinol Nutr; 2009 Feb; 56(2):66-70. PubMed ID: 19627714
[TBL] [Abstract][Full Text] [Related]
6. Progression from newly acquired impaired fasting glucose to type 2 diabetes: response to Nichols et al.
Dinneen SF; Rizza RA
Diabetes Care; 2007 Jul; 30(7):e79; author reply e80. PubMed ID: 17596502
[No Abstract] [Full Text] [Related]
7. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
Harati H; Hadaegh F; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
[TBL] [Abstract][Full Text] [Related]
8. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study.
Pitocco D; Zaccardi F; Di Stasio E; Romitelli F; Santini SA; Ghirlanda G
Diabet Med; 2008 Apr; 25(4):508; author reply 509. PubMed ID: 18294219
[No Abstract] [Full Text] [Related]
10. Fasting blood glucose and diagnosis of type 2 diabetes.
Islam MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):e26. PubMed ID: 21030102
[No Abstract] [Full Text] [Related]
11. Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?
Wong VW; Chan HL
J Gastroenterol Hepatol; 2011 Mar; 26(3):419-20. PubMed ID: 21332536
[No Abstract] [Full Text] [Related]
12. Screening for the detection of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in welfare homes residents from south-eastern region of Poland.
Grzywa M; Mazur A; Skrzypiec J
Int J Clin Pract; 2011 Jul; 65(7):818-9. PubMed ID: 21676124
[No Abstract] [Full Text] [Related]
13. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
Rush E; Crook N; Simmons D
Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
[TBL] [Abstract][Full Text] [Related]
14. High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al.
Dai CY; Chuang WL; Ho CK; Ou TT; Huang JF; Hsieh MY; Yu ML
Diabetes Care; 2008 Sep; 31(9):e67. PubMed ID: 18753663
[No Abstract] [Full Text] [Related]
15. Screening for diabetes: sensitivity and positive predictive value of risk factor total.
Behan KJ
Clin Lab Sci; 2005; 18(4):221-5. PubMed ID: 16315739
[TBL] [Abstract][Full Text] [Related]
16. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes: response to Cho et al.
Gavi S; Qurashi S; Melendez MM; Mynarcik DC; McNurlan MA; Gelato MC
Diabetes Care; 2007 Mar; 30(3):e7; author reply e8. PubMed ID: 17327302
[No Abstract] [Full Text] [Related]
17. Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetes.
Aleil B; Kessler L; Meyer N; Wiesel ML; Simeoni J; Cazenave JP; Pinget M; Gachet C; Lanza F
Thromb Haemost; 2008 Oct; 100(4):713-5. PubMed ID: 18841299
[No Abstract] [Full Text] [Related]
18. Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study.
Raitakari OT; Rönnemaa T; Huupponen R; Viikari L; Fan M; Marniemi J; Hutri-Kähönen N; Viikari JS; Lehtimäki T
Diabetes Care; 2007 Sep; 30(9):2299-301. PubMed ID: 17540954
[No Abstract] [Full Text] [Related]
19. [Main causes of hyperuricemia in diabetes mellitus].
Madianov IV; Balabolkin MI; Markov DS; Markova TN
Ter Arkh; 2000; 72(2):55-8. PubMed ID: 10717929
[TBL] [Abstract][Full Text] [Related]
20. How to diagnose diabetes.
Hill J
Nurs Times; 2005 Apr 19-25; 101(16):28-30. PubMed ID: 15871371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
